Published: May 2025 | Authors: David Turner, PhD — Department of Anatomy & Cell Biology, New Haven Medical Research Institute
Prostate enlargement, also known as benign prostatic hyperplasia (BPH), affects over 80% of men over the age of 50 in the United States. While mainstream medicine attributes this condition to aging and hormonal imbalances, recent findings reveal a hidden and far more dangerous culprit: toxic mineral buildup inside the urinary tract and prostate tissue.
This phenomenon, referred to as toxic urine syndrome, causes chronic prostate inflammation, leading to swelling, urinary retention, pain, and sexual dysfunction.
This article presents breakthrough evidence on how microscopic mineral deposits from contaminated hard tap water in the U.S. are silently attacking the male urinary system. More importantly, it unveils a natural solution — a Japanese-inspired protocol originally developed for aerospace engineers and astronauts — that eliminates this toxic buildup, restores prostate health, and reverses urinary problems quickly and safely.
Most men believe that waking up several times at night to urinate, experiencing weak urine flow, or struggling with declining bedroom performance are normal signs of aging.
This assumption is incorrect.
Recent medical research indicates that the true cause of prostate enlargement is not aging itself, but a toxic layer of mineral buildup, microplastics, and chemical waste accumulating in the prostate and urinary tract.
This harmful sludge is primarily the result of prolonged exposure to contaminated tap water, which contains calcium carbonate, heavy metals, pharmaceutical residues, and microplastics. Much like limescale builds up inside water pipes, these toxic materials gradually coat the urinary system, leading to inflammation and swelling of the prostate.
The result is a cascade of symptoms including:
Peer-reviewed studies from institutions such as Harvard University, Johns Hopkins, and Cleveland Clinic confirm that regions with harder water show significantly higher rates of prostate-related disorders, including BPH.
Data reveals that 44% of tap water samples in the United States fail to meet basic filtration standards. Men exposed to hard water for more than five years face a 79% increased risk of developing prostate enlargement.
This is not a coincidence. The proximity of the prostate to the urinary tract makes it particularly vulnerable to chronic exposure to toxic urine, which leads to ongoing inflammation and tissue overgrowth.
A pivotal breakthrough emerged when Dr. David Turner collaborated with a former medical consultant from the SpaceX aerospace medical division. The consultant revealed that astronauts are required to follow a Zero-Gravity Urine Flow Protocol to avoid urinary retention in space. This specialized regimen was adapted from an ancient Japanese purification ritual designed to eliminate mineral buildup from the urinary tract.
The protocol utilizes specific natural compounds with clinically validated properties that dissolve and expel harmful mineral deposits while supporting prostate tissue repair.
Common medical treatments, including alpha-blockers (e.g., Flomax, Uroxatral) and 5-alpha-reductase inhibitors (e.g., Proscar, Avodart), only offer temporary relief while introducing a wide range of side effects such as dizziness, fatigue, and erectile dysfunction.
Surgical interventions remain expensive ($20,000 to $130,000) and carry substantial risks, including infection, urinary incontinence, and permanent sexual dysfunction.
The cumulative evidence demonstrates that prostate enlargement is not an inevitable consequence of aging but rather a result of chronic toxic mineral buildup damaging the urinary system.
The Japanese aerospace protocol offers a safe, effective, and scientifically validated approach to reversing this condition by targeting the root cause—without surgery or prescription medications.
In response to the success observed in clinical settings, a concentrated natural formula replicating this protocol has been developed for public accessibility. The formulation is available in three package options, each aligned with the dosing schedules used in the referenced studies:
Each bottle is manufactured under stringent GMP standards in FDA-approved facilities, following the precise composition utilized during the clinical evaluations presented in this publication.
Access to the official clinical formulation is currently available through a dedicated distribution channel designed to maintain quality control and ingredient integrity.
Access the official formula here
Due to the limited availability of key ingredients such as Noriyaki leaf and Himalayan Shilajit, supply remains constrained. Distribution operates on a first-come, first-served basis to ensure availability for participants.